What's Happening?
SMi Systems has announced a non-exclusive collaboration with Luminex Corporation to evaluate the use of Luminex beads with SMi's single-molecule imaging platform. The collaboration aims to assess the feasibility and analytical sensitivity of SMi's technology
compared to Luminex's xMAP readers. The evaluation focuses on research activities to validate the potential for SMi's platform to complement Luminex's technology, enhancing the detection capabilities in biomedical research and diagnostics.
Why It's Important?
This collaboration represents a significant step in advancing diagnostic technologies by combining SMi's single-molecule imaging capabilities with Luminex's established xMAP technology. The partnership could lead to improved diagnostic assays, providing more accurate and reliable detection of substances in biomedical research. This advancement has the potential to enhance research outcomes and facilitate earlier and more informed decisions in diagnostics.
What's Next?
The collaboration will continue to focus on research and validation activities, with the potential for further integration of SMi's technology into Luminex's diagnostic platforms. Successful validation could lead to broader adoption of the combined technologies in laboratories, improving diagnostic capabilities and research efficiency.
